The Next Edition
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate
No Result
View All Result
The Next Edition
No Result
View All Result
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate
Home Top News

WHO Announces 3 New Drugs For COVID-19 Clinical Trials

Next Edition by Next Edition
August 11, 2021
in Top News
WHO Warns Against Use Of Masks During Exercise
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on Whatsapp

Three new candidate drugs are being tested in the latest phase of global Solidarity clinical trials to find effective treatments against COVID-19, the World Health Organisation (WHO) announced on Wednesday.

The therapies — artesunate, imatinib and infliximab — will be tested on hospitalised COVID-19 patients in 52 countries under the Solidarity PLUS programme.

You might also like

Federal Civil Service Goes Paperless December

Human Skull Recovered From Enugu Church Site Linked To Child Murder Case

Fed Govt Declares Thursday Public Holiday To Mark June 12

There have been more than 203 million cases of the disease recorded globally as of Wednesday, according to WHO.

The world hit the 200 million mark last week, just six months after cases passed 100 million.

Speaking during a press conference in Geneva, WHO’s Director-General, Dr. Tedros Ghebreyesus underscored the critical need to find more effective and accessible COVID-19 therapeutics.

“We already have many tools to prevent, test for and treat COVID-19, including oxygen, dexamethasone and IL-6 blockers.

“But we need more, for patients at all ends of the clinical spectrum, from mild to severe disease. And we need health workers that are trained to use them in a safe environment,” he said.

The three drugs were selected by an independent panel for their potential in reducing the risk of death in people hospitalised for COVID-19.

They are already being used to treat other conditions.

Artesunate is a medicine for severe malaria, imatinib is used for certain cancers, including leukemia, while infliximab is used to treat Crohn’s Disease, rheumatoid arthritis and other diseases of the immune system.

Manufacturers Ipca, Novartis and Johnson & Johnson, donated the drugs for the trial.

Solidarity PLUS is the largest global collaboration among WHO’s 194 Member States, with thousands of researchers in over 600 hospitals participating.

READ ALSO: FG Approves Over N4bn For Fuelling Police Vehicles

Finland is among the 52 countries taking part, 16 more than the initial Solidarity Trial, and contributes to the COVAX vaccine solidarity initiative.  Two university hospitals in Finland have been the first worldwide to begin the second phase.

Hanna Sarkkinen, the country’s Minister of Social Affairs and Health, said clinical trials had a great potential to save lives.

“Even though there are approximately 3,000 clinical studies on COVID-19, most of them are too small to yield significant information. We need clinical trials that are large enough to bring better treatments for COVID-19 patients,” she said.

Four drugs were evaluated under the initial Solidarity Trial in 2020, which showed that remdesivir, hydroxychloroquine, lopinavir and interferon had little or no effect on hospitalised patients with COVID-19. (NAN)

Tags: Covid-19FACEMASKHealth ministerNCDCvaccinationVACCINES
Next Edition

Next Edition

Recommended For You

Federal Civil Service Goes Paperless December

Federal Civil Service Goes Paperless December

The Federal Government has announced that the civil service will become fully paperless by December 2025. Head of the Civil Service of the Federation, Didi Walson-Jack, made the...

How My Husband, Pastor Killed My 7-Year-Old Son For Money Ritual In Enugu- Wife

Human Skull Recovered From Enugu Church Site Linked To Child Murder Case

In a development in Enugu State, security operatives have discovered a human skull at a church construction site allegedly tied to a suspected ritualist, Prophet Chinedu Solomon Ezedike....

Alt="Mr. Olubunmi Tunji-Ojo, Minister of Interior "

Fed Govt Declares Thursday Public Holiday To Mark June 12

The Federal Government has declared Thursday, June 12, 2025, a public holiday to commemorate this year’s democracy day celebration. Minister of Interior, Dr. Olubunmi Tunji-Ojo, made the declaration...

Eko Electricity Coy Promises Uninterrupted Power Supply During Eid-el-Fitr

Outage: LASG To Restore Electricity To Badagry Communities 

  The Lagos State Government has commenced efforts to restore electricity to communities in the Badagry-West Local Council Development Area (LCDA). Mr Bonu Solomon, the Lawmaker representing Badagry...

Next Post
COVID-19: Oxygen Demand May Hit 750 Cylinders Daily – Lagos Govt

LASG Arrests 30 Persons For Rebuilding Demolished Illegal Structures




Related News

Community Police: Local Vigilante Will Not Bear Arms – Police Insists

PDP South-West Congress: Police Arrest 4 Persons With Guns

I will Work Hard to Deliver Democracy Dividends — Sanwo-Olu

I will Work Hard to Deliver Democracy Dividends — Sanwo-Olu

Oti Ikomi, Fatayi-Williams, Consul General, others to attend Realnews  9th Anniversary Lecture

Oti Ikomi, Fatayi-Williams, Consul General, others to attend Realnews 9th Anniversary Lecture




The Next Edition

Office Address

3B, Agboola Aina street, Off Toyin Street,
Ikeja, Lagos.

Quick Contact Details

Phone:
08033018430
Whatsapp:
08051679910

Email:
[email protected]
[email protected]

Categories

  • Aviation
  • Beauty
  • Breaking News
  • Business
  • Columnists
  • Editorial
  • Entertainment
  • Fashion
  • Featured
  • Football
  • Foreign
  • Headline News
  • Home & Garden
  • Interviews
  • Investigations
  • North Central
  • North East
  • North West
  • Opinion
  • Parenting
  • Politics
  • Relationships
  • South East
  • South West
  • South-South
  • Special Reports
  • Sports
  • Top News
  • Vox Pops

© Next Edition Business Development Limited

  • About Us
  • Advert Rate
  • Contact Us
  • Privacy Policy
  • Terms of Use
No Result
View All Result
  • Home
  • About Us
  • News
  • Featured
  • Investigations
  • Foreign
  • Special Reports
  • Entertainment
  • Interviews
  • Advert Rate

© Next Edition Business Development Limited